“干细胞及转化研究”重点专项 2018 项目安排

2018-05-31 佚名 科技部

“干细胞及转化研究”重点专项 2018 项目安排

关于国家重点研发计划“干细胞及转化研究”重点专项 2018 年度项目安排公示的通知

根据《国务院关于改进加强中央财政科研项目和资金管理的若干意见》(国发 [2014]11 号)、《国务院关于深化中央财政科技计划(专项、基金等)管理改革方案的通知》(国发[2014]64 号)、《国家重点研发计划管理暂行办法》(国科发资[2017]152 号)等文件要求,现将“干细胞及转化研究”重点专项 2018 年度拟立项项目信息进行公示(详见附件)。

公示时间为 2018 年 5 月 29 日至 2018 年 6 月 4 日。对于公示内容有异议者,请于公示期内以传真、电子邮件等方式提交书面材料,逾期不予受理。个人提交的材料请署明真实姓名和联系方式,单位提交的材料请加盖所在单位公章。联系人和联系方式如下:

联 系人:濮润

联系电话:010-88225135

传 真:010-88225200

电子邮件:purun@cncbd.org.cn

中国生物技术发展中心

2018 年 5 月 29 日

附件:


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1687180, encodeId=0ecf168e1802e, content=<a href='/topic/show?id=7e2f932944b' target=_blank style='color:#2F92EE;'>#转化研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93294, encryptionId=7e2f932944b, topicName=转化研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a30c28335723, createdName=ms691033630344116, createdTime=Thu Jul 05 19:10:00 CST 2018, time=2018-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719411, encodeId=33941e19411c4, content=<a href='/topic/show?id=d970958e600' target=_blank style='color:#2F92EE;'>#重点专项#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95876, encryptionId=d970958e600, topicName=重点专项)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c65032711327, createdName=zhmscau, createdTime=Mon Feb 18 18:10:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320229, encodeId=f76b320229c5, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Thu May 31 08:54:29 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320226, encodeId=02ef3202264b, content=好文.值得点赞!认真学习了.把经验应用于实践.为患者解除病痛., beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRuUXgacXpPeW0x8Z3Qr9c3I2kTic4ZIpR29iaftYgkjRcbv982icYMtqANBPYBgPnOia6mVtX76qMXuc/0, createdBy=d85d1636106, createdName=lietome2, createdTime=Thu May 31 08:41:54 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320218, encodeId=1ddd32021807, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Thu May 31 08:35:59 CST 2018, time=2018-05-31, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1687180, encodeId=0ecf168e1802e, content=<a href='/topic/show?id=7e2f932944b' target=_blank style='color:#2F92EE;'>#转化研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93294, encryptionId=7e2f932944b, topicName=转化研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a30c28335723, createdName=ms691033630344116, createdTime=Thu Jul 05 19:10:00 CST 2018, time=2018-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719411, encodeId=33941e19411c4, content=<a href='/topic/show?id=d970958e600' target=_blank style='color:#2F92EE;'>#重点专项#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95876, encryptionId=d970958e600, topicName=重点专项)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c65032711327, createdName=zhmscau, createdTime=Mon Feb 18 18:10:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320229, encodeId=f76b320229c5, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Thu May 31 08:54:29 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320226, encodeId=02ef3202264b, content=好文.值得点赞!认真学习了.把经验应用于实践.为患者解除病痛., beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRuUXgacXpPeW0x8Z3Qr9c3I2kTic4ZIpR29iaftYgkjRcbv982icYMtqANBPYBgPnOia6mVtX76qMXuc/0, createdBy=d85d1636106, createdName=lietome2, createdTime=Thu May 31 08:41:54 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320218, encodeId=1ddd32021807, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Thu May 31 08:35:59 CST 2018, time=2018-05-31, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1687180, encodeId=0ecf168e1802e, content=<a href='/topic/show?id=7e2f932944b' target=_blank style='color:#2F92EE;'>#转化研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93294, encryptionId=7e2f932944b, topicName=转化研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a30c28335723, createdName=ms691033630344116, createdTime=Thu Jul 05 19:10:00 CST 2018, time=2018-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719411, encodeId=33941e19411c4, content=<a href='/topic/show?id=d970958e600' target=_blank style='color:#2F92EE;'>#重点专项#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95876, encryptionId=d970958e600, topicName=重点专项)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c65032711327, createdName=zhmscau, createdTime=Mon Feb 18 18:10:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320229, encodeId=f76b320229c5, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Thu May 31 08:54:29 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320226, encodeId=02ef3202264b, content=好文.值得点赞!认真学习了.把经验应用于实践.为患者解除病痛., beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRuUXgacXpPeW0x8Z3Qr9c3I2kTic4ZIpR29iaftYgkjRcbv982icYMtqANBPYBgPnOia6mVtX76qMXuc/0, createdBy=d85d1636106, createdName=lietome2, createdTime=Thu May 31 08:41:54 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320218, encodeId=1ddd32021807, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Thu May 31 08:35:59 CST 2018, time=2018-05-31, status=1, ipAttribution=)]
    2018-05-31 龙胆草

    学习谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1687180, encodeId=0ecf168e1802e, content=<a href='/topic/show?id=7e2f932944b' target=_blank style='color:#2F92EE;'>#转化研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93294, encryptionId=7e2f932944b, topicName=转化研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a30c28335723, createdName=ms691033630344116, createdTime=Thu Jul 05 19:10:00 CST 2018, time=2018-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719411, encodeId=33941e19411c4, content=<a href='/topic/show?id=d970958e600' target=_blank style='color:#2F92EE;'>#重点专项#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95876, encryptionId=d970958e600, topicName=重点专项)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c65032711327, createdName=zhmscau, createdTime=Mon Feb 18 18:10:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320229, encodeId=f76b320229c5, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Thu May 31 08:54:29 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320226, encodeId=02ef3202264b, content=好文.值得点赞!认真学习了.把经验应用于实践.为患者解除病痛., beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRuUXgacXpPeW0x8Z3Qr9c3I2kTic4ZIpR29iaftYgkjRcbv982icYMtqANBPYBgPnOia6mVtX76qMXuc/0, createdBy=d85d1636106, createdName=lietome2, createdTime=Thu May 31 08:41:54 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320218, encodeId=1ddd32021807, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Thu May 31 08:35:59 CST 2018, time=2018-05-31, status=1, ipAttribution=)]
    2018-05-31 lietome2

    好文.值得点赞!认真学习了.把经验应用于实践.为患者解除病痛.

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1687180, encodeId=0ecf168e1802e, content=<a href='/topic/show?id=7e2f932944b' target=_blank style='color:#2F92EE;'>#转化研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93294, encryptionId=7e2f932944b, topicName=转化研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a30c28335723, createdName=ms691033630344116, createdTime=Thu Jul 05 19:10:00 CST 2018, time=2018-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719411, encodeId=33941e19411c4, content=<a href='/topic/show?id=d970958e600' target=_blank style='color:#2F92EE;'>#重点专项#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95876, encryptionId=d970958e600, topicName=重点专项)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c65032711327, createdName=zhmscau, createdTime=Mon Feb 18 18:10:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320229, encodeId=f76b320229c5, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Thu May 31 08:54:29 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320226, encodeId=02ef3202264b, content=好文.值得点赞!认真学习了.把经验应用于实践.为患者解除病痛., beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRuUXgacXpPeW0x8Z3Qr9c3I2kTic4ZIpR29iaftYgkjRcbv982icYMtqANBPYBgPnOia6mVtX76qMXuc/0, createdBy=d85d1636106, createdName=lietome2, createdTime=Thu May 31 08:41:54 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320218, encodeId=1ddd32021807, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Thu May 31 08:35:59 CST 2018, time=2018-05-31, status=1, ipAttribution=)]
    2018-05-31 明月清辉

    谢谢分享.学习了

    0

相关资讯

Stem Cell Reports:科学家发现特殊的表观遗传标志物 有望治疗癌症及不育等多种人类疾病

近日,一项刊登在国际杂志Stem Cell Reports上的研究报告中,来自马里兰大学的研究人员通过研究发现了一种新型机制,其能指挥种系干细胞或生殖细胞的发育,这种特殊的细胞类型能将遗传信息传递到下一代中,干细胞领域的研究有望帮助研究人员未来有效对抗人类疾病,这项研究中,研究人员发现了能够鉴别雄性生殖细胞的特殊标志物,同时他们还深入阐明了环境因素或表观遗传学因素如何影响这些生殖细胞,这或为开发男

Clin Cancer Res:癌症干细胞和巨噬细胞互作能够促使前列腺癌恶化和增强雄激素阻断治疗抗性

癌症干细胞(CSCs)能够导致前列腺癌的恶化和雄激素阻断治疗(ADT)抗性的增强。由于CSCs依赖于它们特异的微环境,包括肿瘤相关的巨噬细胞(TAMs),阐释CSCs和TAMs之间的互作网络也许能够更加有效的抑制前列腺癌的恶化和对ADT的抗性。研究人员利用RNA-seq、co-IP和其他的试验评估了维持CSCs干细胞特性的细胞内机制,还利用共培养系统和细胞激素抗体试验来检测CSCs和TAMs之间的

Bioact Mater:脂肪来源的干细胞在骨组织工程中的效果优于成骨细胞

骨的超微结构提供了抗压缩、扭转和拉伸应力的独特机械强度。具有羟基磷灰石成核序列的弹性蛋白样重组体(ELR)结合到携带的微通道模式的胶原-丝素蛋白混合物中以刺激各向异性骨生成。 SEM和荧光显微镜显示,脂质衍生干细胞(ADSCs)和人成骨细胞(HOBs)排列在微通道图案化胶原-丝素-ELR共混物膜的脊和沟槽中。未处理膜的杨氏模量和极限拉伸强度(UTS)分别为0.58±0.13MPa和0.18

Colloids Surf B Biointerfaces:氧化石墨烯的尺寸大小影响干细胞的成骨行为

已知石墨烯衍生物适用于生物医学应用,特别是对于基于干细胞的疗法。本研究中,研究人员报道了使用微米级(MGO)和纳米级氧化石墨烯(NGO)片材的氧化石墨烯(GO)对人脂肪来源的间充质干细胞(hADMSCs)分化的尺寸效应。 将具有1-10μm和100-300nm横向尺寸的MGO和NGO片分别通过滴铸涂覆在玻璃基底上。结果发现,与NGO对应物相比,MGO包被的基底上hADMSCs的扩散和增殖速率

Science:巨噬细胞竟是维持乳腺干细胞的“摇篮”

干细胞能够分化成几种不同类型的细胞。乳腺干细胞在青春期促进乳房发育并且在妊娠和哺乳期间是非常活跃的。

Cell Reports:遏制恶性脑瘤的关键酶

5月8日,发表在Cell子刊《Cell Reports》上的一篇最新研究揭示,抑制一种关键酶CDK5,有望有效遏制恶性脑瘤的发展和复发。